Industry News

Delcath Systems, Inc., an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that Company management will participate at the 2016 Aegis Growth Conference taking place from September 20-22, 2016 in Las Vegas. Jennifer K. Simpson, Ph.D., MSN, CRNP, President and Chief Executive Officer of Delcath, will present a corporate overview on September 21st at 2:00 p.m. Pacific time."/>
Delcath To Present At The 2016 Aegis Growth Conference
Ekso Bionics Holdings, Inc., a robotic exoskeleton company, today announced that the company and its collaborators will have ten abstracts with data from 116 patients presented at the International Spinal Cord Society Annual Scientific Meeting taking place September 14-16, 2016 in Vienna, Austria. Of the 116 patients covered by these presentations, data from 54 patients are from the Ekso Bionics-sponsored Pan-Euro Study.. The titles and schedule..."/>
Ekso Bionics Announces New Data to be Presented at 55th ISCoS Annual Scientific Meeting
Air Methods announced the appointment of its first chief medical officer, David Frederick Edward Stuhlmiller, MD, FACEP, CMTE. Mike Allen, president of air medical services at Air Methods said, "We're very pleased to have Dr. Stuhlmiller join our leadership team."/>
Air Methods Announces New Chief Medical Officer
pSivida Corp., a leader in the development of sustained release drug delivery products for treating eye diseases, today provided a Company update and announced financial results for its fourth quarter and fiscal year ended June 30, 2016.. “Fiscal 2016 was a year of substantial progress for pSivida. We significantly advanced Medidur™ for posterior segment uveitis toward planned EU and U.S. marketing applications, progressing toward a treatment..."/>
PSivida Corp. Provides Company Update and Reports Fourth Quarter and FY 2016 Results
Interpace Diagnostics Group, a company that provides clinically useful molecular diagnostic tests and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for better patient diagnosis and management, reported today that two short call abstracts submitted by the Company have been accepted for poster presentations at the upcoming 86th Annual Meeting of the American..."/>
Interpace Diagnostics Invited to Present Data at Upcoming American Thyroid Association (ATA) Annual Meeting
Raptor Pharmaceutical Corp. by Horizon Pharma plc. On September 12, 2016, the two companies announced the signing of a definitive merger agreement pursuant to which Horizon Pharma will acquire Raptor Pharmaceutical. Under the terms of the agreement, Raptor Pharmaceutical shareholders will receive $9.00 for each share of Raptor Pharmaceutical..."/>
Robbins Arroyo LLP: Acquisition of Raptor Pharmaceutical Corp. (RPTP) by Horizon Pharma plc (HZNP) May Not Be in Shareholders' Best Interests
Perrigo Company (NYSE: PRGO; TASE: PRGO, and disappointment over the company's financial results have led activist Starboard Value LP to invest in the drugmaker. Yesterday, "The Wall Street Journal" reported that the fund has acquired a 4.6% stake in Perrigo, shares worth almost $600 million, and urges the company to focus on its core business. This stake was acquired in the past few weeks: at the end of the second quarter, Starboard Value did not hold..."/>
Starboard Value buys 4.6% Perrigo stake [Globes, Tel Aviv, Israel]
Leatt Corporation, a global developer, marketer and distributor of personal protective equipment for all forms of sports, and whose products include the flagship Leatt-Brace ®, announced today that it has expanded its Motocross/Off-Road Range of products for 2017. The new portfolio adds a wide array of apparel designs, as well as high-performance protection gear, including new helmets. The new launch, which was publicly debuted..."/>
Leatt Introduces 2017 Motocross/Off-Road Range of Products
Quorum Health Corporation. Investors who purchased or otherwise acquired Quorum securities: pursuant and/or traceable to Quorum’ s Registration Statement issued in connection with the Company’ s spinoff from Community Health Systems, Inc. effective on or about April 29, 2016; and/or on the open market between May 2, 2016 and August 10, 2016 inclusive, are encouraged to contact the Firm..."/>
INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Quorum Health Corporation and Encourages Investors with Losses to Contact the Firm
Vitality Biopharma, Inc. a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders announced today that Company CEO, Robert Brooke will be presenting at the Rodman& Renshaw 18th Annual Global Investment Conference to be held September 12, 2016, at the Lotte New York Palace Hotel in New York City."/>
Vitality Biopharma to Present at Rodman & Renshaw 18th Annual Global Investment Conference
Chembio Diagnostics, Inc., a leader in point-of-care diagnostic tests for infectious diseases, today announced that John Sperzel, Chembio’ s chief executive officer, will make a corporate presentation at the Rodman& Renshaw Conference being held September 11– 13, 2016, in New York, NY.. Details of the presentation are as follows:. To access the live webcast of Chembio's presentation, please visit the "Calendar of Events" section under the Investors tab at..."/>
Chembio to Present Today at the Rodman & Renshaw 18th Annual Global Investment Conference
PRA Health Sciences unveiled a strategic partnership with Japanese drug giant Takeda Pharmaceutical that will include transferring about 300 employees around the globe to the Raleigh-based pharmaceutical services company. None of the new employees being added will be working in the Triangle, where PRA employs about 500 workers. The two companies announced Monday that PRA will be Takeda's "primary strategic partner" and will "manage an entire pipeline of studies"..."/>
PRA forms partnership with giant Japanese drug company [The News & Observer (Raleigh, N.C.)]
Bavarian Nordic A/S announced today that Janssen Vaccines& Prevention B.V. has completed a submission to the World Health Organization for Emergency Use Assessment and Listing for its investigational preventive Ebola prime-boost vaccine regimen, which includes Bavarian Nordic's MVA-BN ® Filo..."/>
Bavarian Nordic Announces that Janssen has completed a Submission for Emergency Use Assessment and Listing for its Ebola Vaccine Regimen to the World Health Organization
Ossur Hf : Transactions in relation to share buyback program
Repros Therapeutics Inc. ® today announced that, as anticipated, it has activated the process for obtaining a marketing authorization for enclomiphene in the treatment of secondary hypogonadism in Europe. The MAA has been submitted today to the European Medicines Agency by Renable Pharma Limited, the U.K. subsidiary of Repros."/>
Repros Announces Submission of MAA to the European Medicines Agency for Enclomiphene in the Treatment of Secondary Hypogonadism
HMS Holdings Corp. has acquired Longmont, Colorado-based care management platform provider Essette for USD 20 m, the company said. The approximately USD 20 m purchase was funded with available cash. This platform helps risk-bearing healthcare organisations identify, engage, and manage at-risk patient populations to improve outcomes while managing costs."/>
Texas Benefits Coordinator HMS Holdings Acquires Essette for USD 20m
Ensign Group, Inc.' s home health and hospice portfolio subsidiary Meridian, Idaho-based hospices services company Cornerstone Healthcare, Inc. has acquired the assets of Abilene, Texas-based Kinder Hearts Home Health and Hospice, effective 1 September 2016, the company said. Terms of the deal were not disclosed. With the acquisition, Cornerstone subsidiaries now operate 17 home health operations, seventeen hospice..."/>
Ensign Acquires Texas-based Kinder Hearts Home Health and Hospice
Quorum Health Corporation securities on or before August 10, 2016. The deadline to move for appointment as lead plaintiff in the case is November 8, 2016.. The lawsuit, which is pending in the United States District Court for the Middle District of Tennessee, alleges, among other things, that Quorum overstated the performance of its hospitals and its goodwill."/>
INVESTOR ALERT: Class Action Lawsuit on Behalf of Investors in Quorum Health Filed by Holzer & Holzer
Prestige Brands Holdings, Inc., a leading marketer of over-the-counter healthcare products, today announced the appointment of Christine“ Chris” Sacco to the position of Chief Financial Officer for the Company. Sacco is a seasoned public company chief financial officer, bringing more than 19 years of experience in corporate finance, treasury, investor relations, strategic planning, operations and mergers and acquisitions focused on consumer products and..."/>
Prestige Brands Holdings, Inc. Appoints Christine Sacco as New Chief Financial Officer
Genmab A/S. COPENHAGEN, Denmark, Sept. 12, 2016-- Genmab A/S announces under reference to Section 29 of the Danish Securities Trading Act that FIL Investment Management Limited has informed us that, as of September 9, 2016, FMR LLC has decreased their indirect ownership in Genmab A/S to 2,975,738 shares, which amounts to 4.94% of the share capital and voting rights in Genmab A/S.. About Genmab Genmab is a publicly traded, international..."/>
Major Shareholder Announcement

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology531 Articles
Consumer Discretionary470 Articles
Financials300 Articles
Industrials291 Articles
Health Care259 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at